Related Experiment Video
Updated: May 14, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Surgical timing of degenerative mitral regurgitation: what to consider
Maria Consolacion Dolor-Torres1, Lieng H Ling
1Department of Medicine, Yong Loo Lin School of Medicine, Singapore.
Abstract:
Severe primary mitral regurgitation (MR) is a progressive condition which engenders significant mortality and morbidity if left untreated. The optimal timing of surgery in patients with MR of degenerative origin continues to be debated, especially for those who are asymptomatic. Apart from symptoms, current authoritative guidelines recommend intervention when there is incipient left ventricular dysfunction, pulmonary hypertension or new onset atrial fibrillation. This review focuses on the asymptomatic subject with severe MR, and examines contemporary clinical decision-making and management strategies, including the 2012 European guidelines on valvular heart disease. We discuss the rationale for risk stratifying the asymptomatic individual, and highlight current and novel diagnostic tools that may have a useful role, with an emphasis on echocardiographic imaging.
Insights
Severe primary mitral regurgitation (MR) requires timely intervention. This review examines optimal surgical timing for asymptomatic patients with degenerative MR, focusing on risk stratification and diagnostic tools like echocardiography.
Area of Science:
- Cardiology
- Valvular Heart Disease
Background:
- Severe primary mitral regurgitation (MR) is a progressive condition with significant mortality and morbidity.
- Optimal surgical timing for degenerative MR, particularly in asymptomatic patients, remains a clinical debate.
Purpose of the Study:
- To review contemporary clinical decision-making and management strategies for asymptomatic severe MR.
- To examine risk stratification and diagnostic tools for guiding intervention in these patients.
Main Methods:
- Review of current literature and guidelines, including the 2012 European guidelines on valvular heart disease.
- Focus on echocardiographic imaging and other diagnostic modalities for risk assessment.
Main Results:
- Current guidelines suggest intervention for asymptomatic severe MR in cases of incipient left ventricular dysfunction, pulmonary hypertension, or new-onset atrial fibrillation.
- Risk stratification is crucial for identifying asymptomatic patients who would benefit from surgery.
Conclusions:
- Management of asymptomatic severe MR necessitates careful consideration of risk factors and diagnostic findings.
- Echocardiography plays a pivotal role in assessing severity and guiding surgical decisions.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
